New AHA-ACC guidelines could lead to major changes in clinical practice.
Karen
K
Rosenberg
D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000517:prevention & control / Q000628:therapy; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D017410:Practice Guidelines as Topic; D018570:Risk Assessment
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors